1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Fluid Management Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Fluid Management Market Analysis and Forecast, 2017 – 2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Fluid Management Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017 – 2031
6.3.1. Infusion Therapy Systems
6.3.1.1. Infusion Devices
6.3.1.2. IV Access
6.3.1.3. IV Solutions & Products
6.3.2. Renal Systems
6.3.2.1. In-center Hemodialysis Products
6.3.2.2. Home Hemodialysis (HHD) Products
6.3.2.3. Peritoneal Dialysis Products
6.3.2.4. Acute Dialysis Products
6.3.3. Endoscopy Fluid Management Products
6.4. Market Attractiveness Analysis, by Product Type
7. Global Fluid Management Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017 – 2031
7.3.1. Urology
7.3.2. Cardiology
7.3.3. Orthopedic/Osteology
7.3.4. Neurology
7.3.5. Oncology
7.3.6. Gastroenterology
7.3.7. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Fluid Management Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017 – 2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Dialysis Centers
8.3.4. Home Care Settings
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Fluid Management Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017 – 2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Fluid Management Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017 – 2031
10.3.1. Infusion Therapy Systems
10.3.1.1. Infusion Devices
10.3.1.2. IV Access
10.3.1.3. IV Solutions & Products
10.3.2. Renal Systems
10.3.2.1. In-center Hemodialysis Products
10.3.2.2. Home Hemodialysis (HHD) Products
10.3.2.3. Peritoneal Dialysis Products
10.3.2.4. Acute Dialysis Products
10.3.3. Endoscopy Fluid Management Products
10.4. Market Value Forecast, by Application, 2017 – 2031
10.4.1. Urology
10.4.2. Cardiology
10.4.3. Orthopedic/Osteology
10.4.4. Neurology
10.4.5. Oncology
10.4.6. Gastroenterology
10.4.7. Others
10.5. Market Value Forecast, by End-user, 2017 – 2031
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Dialysis Centers
10.5.4. Home Care Settings
10.5.5. Others
10.6. Market Value Forecast, by Country, 2017 – 2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Fluid Management Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017 – 2031
11.3.1. Infusion Therapy Systems
11.3.1.1. Infusion Devices
11.3.1.2. IV Access
11.3.1.3. IV Solutions & Products
11.3.2. Renal Systems
11.3.2.1. In-center Hemodialysis Products
11.3.2.2. Home Hemodialysis (HHD) Products
11.3.2.3. Peritoneal Dialysis Products
11.3.2.4. Acute Dialysis Products
11.3.3. Endoscopy Fluid Management Products
11.4. Market Value Forecast, by Application, 2017 – 2031
11.4.1. Urology
11.4.2. Cardiology
11.4.3. Orthopedic/Osteology
11.4.4. Neurology
11.4.5. Oncology
11.4.6. Gastroenterology
11.4.7. Others
11.5. Market Value Forecast, by End-user, 2017 – 2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Dialysis Centers
11.5.4. Home Care Settings
11.5.5. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Fluid Management Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017 – 2031
12.3.1. Infusion Therapy Systems
12.3.1.1. Infusion Devices
12.3.1.2. IV Access
12.3.1.3. IV Solutions & Products
12.3.2. Renal Systems
12.3.2.1. In-center Hemodialysis Products
12.3.2.2. Home Hemodialysis (HHD) Products
12.3.2.3. Peritoneal Dialysis Products
12.3.2.4. Acute Dialysis Products
12.3.3. Endoscopy Fluid Management Products
12.4. Market Value Forecast, by Application, 2017 – 2031
12.4.1. Urology
12.4.2. Cardiology
12.4.3. Orthopedic/Osteology
12.4.4. Neurology
12.4.5. Oncology
12.4.6. Gastroenterology
12.4.7. Others
12.5. Market Value Forecast, by End-user, 2017 – 2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Dialysis Centers
12.5.4. Home Care Settings
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Fluid Management Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017 – 2031
13.3.1. Infusion Therapy Systems
13.3.1.1. Infusion Devices
13.3.1.2. IV Access
13.3.1.3. IV Solutions & Products
13.3.2. Renal Systems
13.3.2.1. In-center Hemodialysis Products
13.3.2.2. Home Hemodialysis (HHD) Products
13.3.2.3. Peritoneal Dialysis Products
13.3.2.4. Acute Dialysis Products
13.3.3. Endoscopy Fluid Management Products
13.4. Market Value Forecast, by Application, 2017 – 2031
13.4.1. Urology
13.4.2. Cardiology
13.4.3. Orthopedic/Osteology
13.4.4. Neurology
13.4.5. Oncology
13.4.6. Gastroenterology
13.4.7. Others
13.5. Market Value Forecast, by End-user, 2017 – 2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Dialysis Centers
13.5.4. Home Care Settings
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Fluid Management Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017 – 2031
14.3.1. Infusion Therapy Systems
14.3.1.1. Infusion Devices
14.3.1.2. IV Access
14.3.1.3. IV Solutions & Products
14.3.2. Renal Systems
14.3.2.1. In-center Hemodialysis Products
14.3.2.2. Home Hemodialysis (HHD) Products
14.3.2.3. Peritoneal Dialysis Products
14.3.2.4. Acute Dialysis Products
14.3.3. Endoscopy Fluid Management Products
14.4. Market Value Forecast, by Application, 2017 – 2031
14.4.1. Urology
14.4.2. Cardiology
14.4.3. Orthopedic/Osteology
14.4.4. Neurology
14.4.5. Oncology
14.4.6. Gastroenterology
14.4.7. Others
14.5. Market Value Forecast, by End-user, 2017 – 2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Dialysis Centers
14.5.4. Home Care Settings
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Baxter
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. BD
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Smith+Nephew
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. B. Braun SE
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Fresenius SE & Co. KGaA
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Cardinal Health Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Stryker
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Boston Scientific Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Karl Storz SE & Co. KG
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
